1. RADICAL TRACHELECTOMY. THE NORWEGIAN EXPERIENCE. Issue 1 (1st March 2003) Authors: Goderstad, J. M.; Baekelandt, M.; van de Putte, G.; Kristensen, G. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument. (1st July 2001) Authors: Tropé, C.; Kaern, J.; Hogberg, T.; Abeler, V; Hagen, B.; Kristensen, G.; Onsrud, M.; Pettersen, E.; Rosenberg, P.; Sandvei, R.; Sundfor, K.; Vegote, I. Journal: International journal of gynecological cancer Issue: Volume 11(2001)Supplement 1 Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2748 Assessment of associations between disease stage and toxicity with bevacizumab (BEV) in ICON7, a phase III trial of front-line carboplatin/paclitaxel (CP) ± BEV for ovarian cancer (OC). (September 2015) Authors: Embleton, A.C.; Perren, T.J.; Cook, A.; Kent, E.; Pfisterer, J.; Ledermann, J.A.; Pujade-Lauraine, E.; Kristensen, G.; Beale, P.; Cervantes, A.; Farrelly, L.; Kaplan, R.; Parmar, M. K.B.; Oza, A.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2703 Computed tomography is more sensitive than CA 125 in detecting disease progression in patients with platinum-resistant ovarian cancer: Analysis of the AURELIA trial. (September 2015) Authors: Lindeman, K.; Kristensen, G.; Raza Mirza, M.; Davies, L.; Hilpert, F.; Romero, I.; Ayhan, A.; Burges, A.; Rubio, M.J.; Raspagliesi, F.; Huizing, M.; Creemers, G.J.; Lykka, M.; Lee, C.; Gebski, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical trials in gynecological cancer. Issue 3 (1st May 2007) Authors: Trimble, E. L.; Davis, J.; Disaia, P.; Fujiwara, K.; Gaffney, D.; Kristensen, G.; Ledermann, J.; Pfisterer, J.; Quinn, M.; Reed, N.; Schoenfeldt, M.; Thigpen, J. T. Journal: International journal of gynecological cancer Issue: Volume 17:Issue 3(2007) Page Start: 547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. Issue 1 (January 2019) Authors: Hackl, Monika; Van Eycken, Elizabeth; Henau, Kris; Dimitrova, Nadya; Sekerija, Mario; Dušek, Ladislav; Mägi, Margit; Malila, Nea; Leinonen, Maarit; Velten, Michel; Troussard, Xavier; Bouvier, Veronique; Guizard, Anne-Valérie; Bouvier, Anne-Marie; Arveux, Patrick; Maynadié, Marc; Woronoff, Anne-So... Journal: European journal of surgical oncology Issue: Volume 45:Issue 1(2019) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 34LBA Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: A multinational randomised, placebo-controlled, double-blind trial – the GAND-emesis study. (September 2015) Authors: Ruhlmann, C.H.; Christensen, T.B.; Dohn, L.H.; Paludan, M.; Rannengart, E.; Hilpert, F.; Feyer, P.; Kristensen, G.; Keefe, D.; Hansen, O.; Herrstedt, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗